ACRS vs RHI · rev $3.6M vs P/E 21, rev $5.38B
Aclaris Therapeutics Inc (ACRS) versus Robert Half International Inc (RHI) — a side-by-side from cached financials, not a winner call.
Aclaris Therapeutics Inc (ACRS) is a biotechnology company listed on NASDAQ.
Robert Half International Inc (RHI) is a staffing & employment services company listed on US.
Latest reported ACRS revenue for 2026-06-30 was $3.6M. Net income was -$41.3M. Revenue was up 81.6% from 2026-03-31 to 2026-06-30. ACRS currently screens at market cap $615.9M.
Latest reported RHI revenue for 2025-12-31 was $5.38B. Net income was $133.0M. RHI currently screens at market cap $4.38B and trailing P/E 21.4.
ACRS currently screens at market cap $615.9M. RHI currently screens at market cap $4.38B and trailing P/E 21.4.
Not investment advice. Open the ACRS and RHI stock pages for the full models.
Not investment advice.